Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Troponin measurements, myocardial infarction diagnoses and outcomes. An analysis of linked data from New South Wales, Australia.

French J, Brieger D, Juergens C, Costa B, Carr B, Chew DP, Briffa T.

Intern Med J. 2019 Aug 19. doi: 10.1111/imj.14614. [Epub ahead of print]

PMID:
31424594
2.

Incidence and predictors of left ventricular thrombus formation following acute ST-segment elevation myocardial infarction: A serial cardiac MRI study.

Phan J, Nguyen T, French J, Moses D, Schlaphoff G, Lo S, Juergens C, Dimitri H, Richards D, Thomas L.

Int J Cardiol Heart Vasc. 2019 Jul 4;24:100395. doi: 10.1016/j.ijcha.2019.100395. eCollection 2019 Sep.

3.

Revascularization Strategies in Patients With STEMI: Culprit-Only vs Multivessel Revascularization Using Percutaneous Coronary Intervention.

Alsadat N, Hyun K, D'Souza M, Chew D, Weaver J, Juergens C, Kritharides L, Hammett C, Brieger D.

J Invasive Cardiol. 2019 Jul 15. pii: JIC2019715-1. [Epub ahead of print]

4.

Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study.

Hee L, Gibbs OJ, Assad JG, Sharma LD, Hopkins A, Juergens CP, Lo S, Mussap CJ.

J Saudi Heart Assoc. 2019 Oct;31(4):151-160. doi: 10.1016/j.jsha.2019.05.005. Epub 2019 May 31.

5.

Assessing Coronary Microvascular Dysfunction in Ischaemic Heart Disease: Little Things Can Make a Big Difference.

Xu J, Lo S, Juergens CP, Leung DY.

Heart Lung Circ. 2019 Jun 22. pii: S1443-9506(19)31324-1. doi: 10.1016/j.hlc.2019.05.187. [Epub ahead of print] Review.

PMID:
31255478
6.

Success of tympanic membrane repair following palatoplasty.

Juergens C, Vaughn A, Kreitman Y, Chen W, Hill G.

Int J Pediatr Otorhinolaryngol. 2019 Sep;124:85-89. doi: 10.1016/j.ijporl.2019.05.042. Epub 2019 May 29.

PMID:
31174023
7.

Standard versus ultrasound-guided radial and femoral access in coronary angiography and intervention (SURF): a randomised controlled trial.

Nguyen P, Makris A, Hennessy A, Jayanti S, Wang A, Park K, Chen V, Nguyen T, Lo S, Xuan W, Leung M, Juergens C.

EuroIntervention. 2019 Aug 9;15(6):e522-e530. doi: 10.4244/EIJ-D-19-00336.

8.

Type-II myocardial infarction and chronic myocardial injury rates, invasive management, and 4-year mortality among consecutive patients undergoing high-sensitivity troponin T testing in the emergency department.

Etaher A, Gibbs OJ, Saad YM, Frost S, Nguyen TL, Ferguson I, Juergens CP, Chew D, French JK.

Eur Heart J Qual Care Clin Outcomes. 2019 May 20. pii: qcz019. doi: 10.1093/ehjqcco/qcz019. [Epub ahead of print]

PMID:
31111144
9.

The impact of incomplete revascularization on early and late outcomes in ST-elevation myocardial infarction.

Burgess SN, French JK, Nguyen TL, Leung M, Richards DAB, Thomas L, Mussap C, Lo S, Juergens CP.

Am Heart J. 2018 Nov;205:31-41. doi: 10.1016/j.ahj.2018.07.017. Epub 2018 Jul 29.

PMID:
30153623
10.

Differences in management and outcomes for men and women with ST-elevation myocardial infarction.

Khan E, Brieger D, Amerena J, Atherton JJ, Chew DP, Farshid A, Ilton M, Juergens CP, Kangaharan N, Rajaratnam R, Sweeny A, Walters DL, Chow CK.

Med J Aust. 2018 Aug 6;209(3):118-123. Epub 2018 Jul 23.

PMID:
30025513
11.

Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations.

Juergens C, Trammel J, Shoji Y, Patterson S, Watson W, Webber C, Gruber WC, Scott DA, Schmoele-Thoma B.

Hum Vaccin Immunother. 2018;14(8):1948-1956. doi: 10.1080/21645515.2018.1452576. Epub 2018 Apr 13.

12.

Clinical and Angiographic Predictors of Mortality in Sudden Cardiac Arrest Patients Having Cardiac Catheterisation: A Single Centre Registry.

Xu J, Hee L, Hopkins A, Juergens CP, Lo S, French JK, Mussap CJ.

Heart Lung Circ. 2019 Mar;28(3):370-378. doi: 10.1016/j.hlc.2018.01.005. Epub 2018 Feb 8.

PMID:
29459218
13.

Decreased opioid consumption and enhance recovery with the addition of IV Acetaminophen in colorectal patients: a prospective, multi-institutional, randomized, double-blinded, placebo-controlled study (DOCIVA study).

Aryaie AH, Lalezari S, Sergent WK, Puckett Y, Juergens C, Ratermann C, Ogg C.

Surg Endosc. 2018 Aug;32(8):3432-3438. doi: 10.1007/s00464-018-6062-y. Epub 2018 Jan 19.

PMID:
29352454
14.

Serotype-specific immune responses to pneumococcal conjugate vaccine among children are significantly correlated by individual: Analysis of randomized controlled trial data.

Lipsitch M, Li LM, Patterson S, Trammel J, Juergens C, Gruber WC, Scott DA, Dagan R.

Vaccine. 2018 Jan 25;36(4):473-478. doi: 10.1016/j.vaccine.2017.12.015. Epub 2017 Dec 14.

15.

Has invasive management for acute coronary syndromes become more 'risk-appropriate': pooled results of five Australian registries.

Halabi A, Chew DP, Horsfall M, Huyn K, MacIsaac A, Juergens C, Amerena J, Rankin J, French J, Brieger D.

Eur Heart J Qual Care Clin Outcomes. 2017 Apr 1;3(2):133-140. doi: 10.1093/ehjqcco/qcw038.

PMID:
28927174
16.

Validation of the RETRIEVE (REverse TRIage EVEnts) Criteria for Same Day Return of Non-ST Elevation Acute Coronary Syndrome Patients to Referring Non-PCI Centres.

Burgess SN, Nguyen VH, Xu J, Hinde Y, Dharmadmajan A, Brennan X, Owen K, Lintern K, Juergens C, Lo S, Nguyen P, Kadappu KK, French JK, Rajaratnam R.

Heart Lung Circ. 2018 Jul;27(7):792-797. doi: 10.1016/j.hlc.2017.08.005. Epub 2017 Aug 19.

PMID:
28919071
17.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine in adults 50 to 65 years of age in India: An open-label trial.

Solanki BB, Juergens C, Chopada MB, Supe P, Sundaraiyer V, Le Dren-Narayanin N, Cutler MW, Gruber WC, Scott DA, Schmoele-Thoma B.

Hum Vaccin Immunother. 2017 Sep 2;13(9):2065-2071. doi: 10.1080/21645515.2017.1331796.

18.

Detecting Unknown Artificial Urban Surface Materials Based on Spectral Dissimilarity Analysis.

Jilge M, Heiden U, Habermeyer M, Mende A, Juergens C.

Sensors (Basel). 2017 Aug 8;17(8). pii: E1826. doi: 10.3390/s17081826.

19.

Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine in Children 6-17 Years of Age in India: An Open-label Trial.

Agarkhedkar S, Juergens C, Balasundaram K, Agarkhedkar S, Sundaraiyer V, Le Dren-Narayanin N, Cutler MW, Gruber WC, Scott DA, Schmoele-Thoma B; B1851140 Study Team.

Pediatr Infect Dis J. 2017 Nov;36(11):e283-e285. doi: 10.1097/INF.0000000000001695.

PMID:
28719496
20.

The underutilisation of dual antiplatelet therapy in acute coronary syndrome.

Anastasius M, Lau JK, Hyun K, D'Souza M, Patel A, Rankin J, Walters D, Juergens C, Aliprandi-Costa B, Yan AT, Goodman SG, Chew D, Brieger D.

Int J Cardiol. 2017 Aug 1;240:30-36. doi: 10.1016/j.ijcard.2017.04.077. Epub 2017 Apr 25.

PMID:
28476519
21.

Evaluation of Serial High Sensitivity Troponin T Levels in Individuals Without Overt Coronary Heart Disease Following Exercise Stress Testing.

Saad YME, Idris H, Shugman IM, Kadappu KK, Rajaratnam R, Thomas L, Mussap C, Leung DYC, Juergens CP, French JK.

Heart Lung Circ. 2017 Jul;26(7):660-666. doi: 10.1016/j.hlc.2016.11.004. Epub 2016 Dec 9.

PMID:
28087154
22.

PCV13-vaccinated children still carrying PCV13 additional serotypes show similar carriage density to a control group of PCV7-vaccinated children.

Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gruber WC, Scott DA.

Vaccine. 2017 Feb 7;35(6):945-950. doi: 10.1016/j.vaccine.2016.12.052. Epub 2017 Jan 11.

PMID:
28087146
23.

Influence of Age and Gender on Clinical Outcomes Following Percutaneous Coronary Intervention for Acute Coronary Syndromes.

Idris H, French JK, Shugman IM, Hopkins AP, Juergens CP, Thomas L.

Heart Lung Circ. 2017 Jun;26(6):554-565. doi: 10.1016/j.hlc.2016.10.021. Epub 2016 Dec 2.

PMID:
28034708
24.

Automated hand hygiene auditing with and without an intervention.

Kwok YLA, Juergens CP, McLaws ML.

Am J Infect Control. 2016 Dec 1;44(12):1475-1480. doi: 10.1016/j.ajic.2016.08.014. Epub 2016 Oct 21.

PMID:
27776819
25.

Adverse diastolic remodeling after reperfused ST-elevation myocardial infarction: An important prognostic indicator.

Nguyen TL, Phan J, Hogan J, Hee L, Moses D, Otton J, Premawardhana U, Rajaratnam R, Juergens CP, Dimitri H, French JK, Richards D, Thomas L.

Am Heart J. 2016 Oct;180:117-27. doi: 10.1016/j.ahj.2016.05.020. Epub 2016 Jul 7.

PMID:
27659890
26.

English as a second language and outcomes of patients presenting with acute coronary syndromes: results from the CONCORDANCE registry.

Juergens CP, French JK, Brieger DB.

Med J Aust. 2016 Aug 1;205(3):140. No abstract available.

PMID:
27465772
27.

Modeling pneumococcal nasopharyngeal acquisition as a function of anticapsular serum antibody concentrations after pneumococcal conjugate vaccine administration.

Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gruber WC, Scott DA.

Vaccine. 2016 Aug 5;34(36):4313-20. doi: 10.1016/j.vaccine.2016.06.075. Epub 2016 Jul 12.

PMID:
27422342
28.

Electrocardiographic measurement of infarct size compared to cardiac MRI in reperfused first time ST-segment elevation myocardial infarction.

Holmes LE, Nguyen TL, Hee L, Otton J, Moses DA, French JK, Thomas L, Richards DA, Juergens CP.

Int J Cardiol. 2016 Oct 1;220:389-94. doi: 10.1016/j.ijcard.2016.06.171. Epub 2016 Jun 26.

PMID:
27390960
29.

Prognostic value of high sensitivity troponin T after ST-segment elevation myocardial infarction in the era of cardiac magnetic resonance imaging.

Nguyen TL, French JK, Hogan J, Hee L, Moses D, Mussap CJ, Rajaratnam R, Juergens CP, Dimitri HR, Richards DAB, Thomas L.

Eur Heart J Qual Care Clin Outcomes. 2016 Jul 1;2(3):164-171. doi: 10.1093/ehjqcco/qcv033.

PMID:
29474609
30.
31.

An electronically instrumented internal fixator for the assessment of bone healing.

Kienast B, Kowald B, Seide K, Aljudaibi M, Faschingbauer M, Juergens C, Gille J.

Bone Joint Res. 2016 May;5(5):191-7. doi: 10.1302/2046-3758.55.2000611.

32.

Late clinical outcomes for SeQuent please paclitaxel-coated balloons in PCI of instent restenosis and de novo lesions: A single-center, real world registry.

Hee L, Terluk A, Thomas L, Hopkins A, Juergens CP, Lo S, French JK, Mussap CJ.

Catheter Cardiovasc Interv. 2017 Feb 15;89(3):375-382. doi: 10.1002/ccd.26546. Epub 2016 Apr 26.

PMID:
27113534
33.

An average hand hygiene day for nurses and physicians: The burden is not equal.

Azim S, Juergens C, McLaws ML.

Am J Infect Control. 2016 Jul 1;44(7):777-81. doi: 10.1016/j.ajic.2016.02.006. Epub 2016 Mar 31.

PMID:
27040570
34.

Introducing automated hand hygiene surveillance to an Australian hospital: Mirroring the HOW2 Benchmark Study.

Azim S, Juergens C, Hines J, McLaws ML.

Am J Infect Control. 2016 Jul 1;44(7):772-6. doi: 10.1016/j.ajic.2016.02.012. Epub 2016 Mar 31.

PMID:
27040569
35.

Falling cholesterol trend at acute coronary syndrome presentation is strongly related to statin use for secondary prevention.

Chan T, Dabin B, Hyun K, Ranasinghe I, Neubeck L, Aliprandi-Costa B, Lefkovits J, Devlin G, Juergens C, Chew DP, Brieger D, Freedman SB.

Int J Cardiol. 2016 Jun 1;212:192-7. doi: 10.1016/j.ijcard.2016.03.038. Epub 2016 Mar 16.

PMID:
27038732
36.

English as a second language and outcomes of patients presenting with acute coronary syndromes: results from the CONCORDANCE registry.

Juergens CP, Dabin B, French JK, Kritharides L, Hyun K, Kilian J, Chew DP, Brieger D.

Med J Aust. 2016 Apr 4;204(6):239.

PMID:
27031399
37.

Patients' Adherence in the Maintenance Therapy of Children and Adolescents with Acute Lymphoblastic Leukemia.

Kremeike K, Juergens C, Alz H, Reinhardt D.

Klin Padiatr. 2015 Nov;227(6-7):329-34. doi: 10.1055/s-0035-1559788. Epub 2015 Oct 12.

PMID:
26457956
38.

High-sensitivity troponin T predicts infarct scar characteristics and adverse left ventricular function by cardiac magnetic resonance imaging early after reperfused acute myocardial infarction.

Nguyen TL, Phan JA, Hee L, Moses DA, Otton J, Terreblanche OD, Xiong J, Premawardhana U, Rajaratnam R, Juergens CP, Dimitri HR, French JK, Richards DA, Thomas L.

Am Heart J. 2015 Oct;170(4):715-725.e2. doi: 10.1016/j.ahj.2015.06.022. Epub 2015 Jul 2.

PMID:
26386795
39.

Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults.

Shiramoto M, Hanada R, Juergens C, Shoji Y, Yoshida M, Ballan B, Cooper D, Gruber WC, Scott DA, Schmoele-Thoma B.

Hum Vaccin Immunother. 2015;11(9):2198-206. doi: 10.1080/21645515.2015.1030550. Epub 2015 Jul 15.

40.

Use of a high-sensitivity troponin T assay in the assessment and disposition of patients attending a tertiary Australian emergency department: a cross-sectional pilot study.

Saad YM, McEwan J, Shugman IM, Mussap C, Juergens CP, Ferguson I, French JK.

Emerg Med Australas. 2015 Oct;27(5):405-11. doi: 10.1111/1742-6723.12430. Epub 2015 Jun 26.

PMID:
26114735
41.

"Target-lesion" SYNTAX score (tSS) determines radiation dose in percutaneous coronary intervention.

Hee L, Thomas L, Ullah I, Juergens CP, Lo S, Hopkins A, French JK, Mussap CJ.

J Interv Cardiol. 2015 Apr;28(2):157-63. doi: 10.1111/joic.12186.

PMID:
25884899
42.

Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study.

Cordonnier C, Ljungman P, Juergens C, Maertens J, Selleslag D, Sundaraiyer V, Giardina PC, Clarke K, Gruber WC, Scott DA, Schmoele-Thoma B; 3003 Study Group.

Clin Infect Dis. 2015 Aug 1;61(3):313-23. doi: 10.1093/cid/civ287. Epub 2015 Apr 13.

43.

Safety and efficacy of same-day discharge following elective percutaneous coronary intervention, including evaluation of next day troponin T levels.

Saad Y, Shugman IM, Kumar M, Pauk I, Mussap C, Hopkins AP, Rajaratnam R, Lo S, Juergens CP, French JK.

Heart Lung Circ. 2015 Apr;24(4):368-76. doi: 10.1016/j.hlc.2014.11.011. Epub 2014 Nov 26.

PMID:
25524564
44.

Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.

Tinoco JC, Juergens C, Ruiz Palacios GM, Vazquez-Narvaez J, Enkerlin-Pauwells HL, Sundaraiyer V, Pathirana S, Kalinina E, Gruber WC, Scott DA, Schmoele-Thoma B.

Clin Vaccine Immunol. 2015 Feb;22(2):185-92. doi: 10.1128/CVI.00711-14. Epub 2014 Dec 10.

45.

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine when administered to healthy Japanese adults aged ≥50 years. An open-label trial.

Shiramoto M, Irie S, Juergens C, Yamaji M, Tamai S, Aizawa M, Belanger T, Gruber WC, Scott DA, Schmoele-Thoma B.

Hum Vaccin Immunother. 2014;10(7):1850-8. doi: 10.4161/hv.28633.

46.

Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications.

Idris H, Lo S, Shugman IM, Saad Y, Hopkins AP, Mussap C, Leung D, Thomas L, Juergens CP, French JK.

J Am Heart Assoc. 2014 Oct 30;3(6):e001086. doi: 10.1161/JAHA.114.001086.

47.

Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.

Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Givon-Lavi N, Porat N, Gurtman A, Gruber WC, Scott DA.

J Infect Dis. 2015 Apr 1;211(7):1144-53. doi: 10.1093/infdis/jiu576. Epub 2014 Oct 29.

PMID:
25355940
48.

Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization.

Juergens C, Patterson S, Trammel J, Greenberg D, Givon-Lavi N, Cooper D, Gurtman A, Gruber WC, Scott DA, Dagan R.

Clin Vaccine Immunol. 2014 Sep;21(9):1277-81. doi: 10.1128/CVI.00172-14. Epub 2014 Jul 2.

49.

Long-term outcomes in patients with restrictive filling following ST-segment elevation myocardial infarction.

Hee L, Brennan X, Chen J, Allman C, Whalley GA, French JK, Juergens CP, Thomas L.

Intern Med J. 2014 Mar;44(3):291-4. doi: 10.1111/imj.12360.

PMID:
24621285
50.

Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine formulations with and without aluminum phosphate and comparison of the formulation of choice with 23-valent pneumococcal polysaccharide vaccine in elderly adults: a randomized open-label trial.

Juergens C, de Villiers PJ, Moodley K, Jayawardene D, Jansen KU, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B.

Hum Vaccin Immunother. 2014;10(5):1343-53. doi: 10.4161/hv.27998. Epub 2014 Feb 27.

Supplemental Content

Loading ...
Support Center